Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma.

scientific article published on 18 February 2010

Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1349-7006.2010.01536.X
P698PubMed publication ID20331628
P5875ResearchGate publication ID42440105

P50authorJae-Won JohQ38640820
P2093author name stringJongmin Kim
Hee Jung Wang
Eun Kyu Lee
Sun Young Park
Jin Young Park
Kwan Yong Choi
In-Gu Do
Jun Ho Park
Seung Sam Paik
Dae Shick Kim
Kyeong Geun Lee
Eun Kyung Lim
Seok Joo Hong
Yun-Suk Yu
Korea Cancer Biomarker Consortium
P2860cites workGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerQ29615523
Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assayQ31034429
The prognostic molecular markers in hepatocellular carcinomaQ34668320
P433issue6
P304page(s)1521-1528
P577publication date2010-02-18
P1433published inCancer ScienceQ326125
P1476titleEpithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma.
P478volume101

Reverse relations

cites work (P2860)
Q92639496A pipeline to create predictive functional networks: application to the tumor progression of hepatocellular carcinoma
Q87781402Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC
Q38799717Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells
Q36390845CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer
Q38046107Cellular and molecular mechanisms of hepatocellular carcinoma: an update
Q58689162Chronic Hypoxia Emerging as One of the Driving Forces behind Gene Expression and Prognosis of Hepatocellular Carcinoma
Q34652699E47 and Id1 interplay in epithelial-mesenchymal transition
Q38673790EMT: Present and future in clinical oncology
Q39230141Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma
Q26783554Epithelial to Mesenchymal Transition in a Clinical Perspective
Q92976721Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network
Q38437954Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma
Q38733791Introduction of ID2 Enhances Invasiveness in ID2-null Oral Squamous Cell Carcinoma Cells via the SNAIL Axis
Q28082679Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer
Q52583955Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy.
Q39399257Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells
Q35835217Snail interacts with Id2 in the regulation of TNF-α-induced cancer cell invasion and migration in OSCC.
Q60961386The Epigenetic Regulation of HCC Metastasis
Q33583133The acute transcriptomic and proteomic response of HC-04 hepatoma cells to hepatocyte growth factor and its implications for Plasmodium falciparum sporozoite invasion.
Q37800793Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets
Q59808241Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas
Q36143130miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma

Search more.